No icon

Passion IT Framework

New research: Drug for common bowel disorder found to blunt Covid-19 vaccine response

People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of Covid-19 vaccine, say the authors of a large-scale study that found many had poor antibody responses.

Read More at:

https://indianexpress.com/article/explained/covid-vaccination-bowel-disorder-drug-research-7290849/

Comment